STAT+: Pharmalittle: We’re reading about the FDA warning Novo Nordisk, Lilly investing in China, and more

Hello, everyone, and welcome to the middle of the week. Congratulations on making it this far. It is an accomplishment, after all. The next step is to … keep going. And why not? Just consider the alternatives. On that optimistic note, please join us for a needed cuppa stimul...

🔗 Read more: https://www.statnews.com/pharmalot/2026/03/11/trump-wegovy-novo-ozempic-lilly-china-autism-fda/?utm_campaign=rss

#News #Medicine #Policy #Biology #Europe #Business #Science